Catalent Pharma Solutions

Company News

Aucta Pharmaceuticals Signs Commercial Manufacturing Agreement with Catalent for Vigabatrin Stick Pack Dosage Form

SOMERSET, N.J. (PRWEB) SEPTEMBER 04, 2018 - Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced a commercial supply agreement with Aucta Pharmaceuticals, Inc.’s (Aucta) vigabatrin. The agreement follows a successful development program to formulate vigabatrin into a...

Read More »
Company News

Catalent Completes $4.6 Million Expansion at Singapore Clinical Supply Facility

SOMERSET, N.J AND PHAR-EAST, SINGAPORE - FEBRUARY 28, 2018 - Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the completion of a two-year, $4.6 million expansion at its Singapore clinical supply facility. The company made the announcement at the PHAR-EAST Pharma...

Read More »

All Topics